Lyka Labs P/E Ratio
Lyka Labs (LYKALABS) P/E ratio is not applicable — EPS (TTM) ₹2.22, 1 consecutive loss quarter. See Healthcare peers with valid P/E ratios below.
P/E Ratio Status
N/A
Loss Making
Company is currently reporting losses
P/E Ratio Not Applicable
Company reported a loss in the most recent quarter. P/E ratio is not meaningful for loss-making periods.
Consecutive Loss Quarters: 1
Current EPS: ₹2.22
Recent Quarterly Performance
| Quarter | EPS (₹) | Net Profit (₹ Cr) | Status |
|---|---|---|---|
| Sept 2025 | -0.94 | -3 | Loss |
| Mar 2025 | 0.49 | 2 | Profit |
| Jun 2025 | 0.25 | 1 | Profit |
| Sept 2024 | 0.58 | 2 | Profit |
| Mar 2024 | -3.83 | -2 | Loss |
| Jun 2024 | 0.40 | 1 | Profit |
| Dec 2024 | 0.75 | 3 | Profit |
| Sept 2023 | -0.15 | -1 | Loss |
Healthcare Peers with Valid P/E Ratios — LYKALABS Comparison
Healthcare sector average P/E 49.88, median 29.34 — LYKALABS excluded (negative EPS).
Sector Average PE
49.88
Sector Median PE
29.34
Lowest PE
1.0
Profitable Companies
191
| Company | Symbol | P/E Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Welcure Drugs & Pharmace… | WELCURE | 1.0 | ₹36 | Low |
| Murae Organisor | MURAE | 2.86 | ₹41 | Low |
| Phaarmasia | PHRMASI | 3.45 | ₹61 | Low |
| Ind Swift Laboratories | INDSWFTLAB | 4.69 | ₹1,161 | Low |
| Amwill Health Care | AMWILL | 6.34 | ₹65 | Low |
| Brooks Laboratories | BROOKS | 6.6 | ₹137 | Low |
| Mono Pharmacare | MONOPHARMA | 7.1 | ₹21 | Low |
| Shelter Pharma | SHELTER | 7.4 | ₹54 | Low |
| Medicamen Organics | MEDIORG | 7.51 | ₹32 | Low |
| Zenith Drugs | ZENITHDRUG | 7.69 | ₹66 | Low |
Related Analysis
- For live price, revenue and the complete fundamental profile, see LYKALABS share price screener.
- Browse LYKALABS annual financials for revenue, profit, balance sheet and cash flow data.
- Analyse LYKALABS promoter holding to track promoter, FII and institutional holdings.